Diflucan Related Published Studies
Well-designed clinical trials related to Diflucan (Fluconazole)
A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. [2009.06.15]
The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. [2009.04]
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. [2009.03]
Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. [2009.02.02]
Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. [2009.01.05]
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. [2009.01]
Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial. [2008.11.15]
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. [2008.07.15]
Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? [2008.06]
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. [2008.05]
Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles. [2008.01]
Effects of nystatin, fluconazole and propolis on poly(methyl methacrylate) resin surface. [2008]
Fluconazole Prophylaxis against Fungal Colonization and Invasive Fungal Infection in Very Low Birth Weight Infants. [2007.11.07]
[The impact of itraconazol versuse fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation] [2007.11]
Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. [2007.11]
Bioavailability of oral fluconazole in critically ill abdominal trauma patients with and without abdominal wall closure: a randomized crossover clinical trial. [2007.07]
A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. [2007.06.14]
Anidulafungin versus fluconazole for invasive candidiasis. [2007.06.14]
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. [2007.01.25]
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. [2007.01.25]
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. [2007.01]
Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients. [2006.08]
A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients. [2006.07]
Terbinafine versus itraconazole and fluconazole in the treatment of Vulvovaginal candidiasis. [2006.07]
Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen. [2006.06]
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS. [2006.04.15]
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg. [2006.04]
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. [2006.02]
Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. [2006.01]
Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. [2006.01]
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. [2005.12]
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40. [2005.11.15]
A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. [2005.11]
Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. [2005.11]
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. [2005.10.22]
A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. [2005.10]
Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. [2005.09]
Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. [2005.08]
Bioequivalence evaluation of two formulations of fluconazole 150 mg capsule in healthy Arab men. [2005.05]
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. [2005.04.01]
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant. [2005.04]
Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. [2005.02]
Evaluation of the bioequivalence of capsules containing 150 mg of fluconazole. [2005.01.06]
The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283). [2004.12]
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. [2004.11.15]
Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study. [2004.11]
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283). [2004.10]
A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. [2004.09.15]
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. [2004.09.15]
Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. [2004.08.26]
Impact of fluconazole prophylaxis on cortisol levels in critically ill surgical patients. [2004.07]
Pharmacokinetics of fosfluconazole and fluconazole following multiple intravenous administration of fosfluconazole in healthy male volunteers. [2004.07]
An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. [2004.06]
Comparison of the pharmacokinetics of fosfluconazole and fluconazole after single intravenous administration of fosfluconazole in healthy Japanese and Caucasian volunteers. [2004.06]
A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. [2004.04]
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. [2004.02.15]
Lumiracoxib: pharmacokinetic and pharmacodynamic profile when coadministered with fluconazole in healthy subjects. [2004.02]
Correlation of in vitro itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis. [2004.01]
Bioequivalence study of two fluconazole capsule formulations in healthy volunteers. [2004.01]
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. [2004.01]
Truncated AUC in the evaluation of fluconazole bioequivalence. A cross-over, randomised, open-label study in healthy volunteers. [2004]
Single-dose fluconazole versus itraconazole in pityriasis versicolor. [2004]
Ciprofloxacin-tinidazole combination, fluconazole- azithromicin-secnidazole-kit and doxycycline- metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. [2003.12]
Fluconazole improves survival in septic shock: a randomized double-blind prospective study. [2003.07]
Effect of fluconazole on the pharmacokinetics and pharmacodynamics of nateglinide. [2003.07]
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. [2003.05.15]
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial. [2003.05.06]
Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit. [2003.05]
The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients. [2003.04]
Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study. [2003.02.10]
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. [2003.01.15]
Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. [2002.12]
Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation. [2002.12]
The effect of fluconazole on the pharmacokinetics of rosuvastatin. [2002.11]
Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. [2002.09]
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. [2002.09]
Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial. [2002.08]
A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis. [2002.06]
Fluconazole versus ketoconazole in the treatment of tinea versicolor. [2002.06]
Enteral fluconazole is well absorbed in critically ill surgical patients. [2002.05]
Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. [2002.04.01]
Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. [2002.03.21]
An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis. [2002.03]
Absence of clinically relevant drug interactions following simultaneous administration of didanosine-encapsulated, enteric-coated bead formulation with either itraconazole or fluconazole. [2002.03]
Effect of fluconazole on the pharmacokinetics and pharmacodynamics of oral and rectal bromazepam: an application of electroencephalography as the pharmacodynamic method. [2002.02]
Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis. [2002]
Fluconazole prophylaxis against fungal colonization and infection in preterm infants. [2001.12.06]
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. [2001.11.01]
Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis. [2001.10.01]
Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study. [2001.10]
Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. [2001.09]
Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. [2001.08]
Evaluation of interaction between fluconazole and an oral contraceptive in healthy women. [2001.08]
Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. [2001.06]
Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride. [2001.04]
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. [2001.04]
Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. [2001.02]
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. [2001]
Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study. [2000.12]
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. [2000.11.07]
Comparative bioavailability of two fluconazole capsule formulations in healthy volunteers. [2000.11]
|
